DAFNA Capital Management »

Ibio shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $368k 194k 1.90

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
Day One Biopharmaceuticals I (DAWN)
AtriCure (ATRC)
Ideaya Biosciences (IDYA)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Compass Pathways Sponsored Ads (CMPS)
Nektar Therapeutics Com New (NKTR)
Ishares Nasdaq Biotech Indx Etf (IBB)
Arcus Biosciences Incorporated (RCUS)
Neurocrine Biosciences (NBIX)
Larimar Therapeutics (LRMR)
Bicara Therapeutics (BCAX)

View all positions for DAFNA Capital Management

Top funds holding Ibio

Affinity Asset Advisors
Frazier Life Sciences Management
EcoR1 Capital
Millennium Management
Logos Global Management
Vanguard Capital Management
Balyasny Asset Management
Ikarian Capital
Citadel Advisors
Vanguard Group
Sio Capital Management
ADAR1 Capital Management
Two Sigma Investments
Walleye Trading Advisors
Geode Capital Management

View all funds holding Ibio